MDT
Medtronic plc · Healthcare · Medical - Devices
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -3.1% · net new positions 0.0% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 1.44M | $115.59M | n/a | −2 |
| Q2 2026 | 172 | +1 | 851.51M | $67.87B | +6 | −7 |
| Q1 2026 | 176 | +1 | 881.81M | $77.21B | +3 | −3 |
| Q4 2025 | 174 | 0 | 922.24M | $88.62B | +1 | n/a |
| Q3 2025 | 25 | -2 | 519.60M | $49.51B | n/a | −3 |
| Q2 2025 | 25 | +1 | 407.26M | $35.53B | +1 | n/a |
| Q1 2025 | 21 | 0 | 149.92M | $13.50B | +1 | −1 |
| Q4 2024 | 21 | -1 | 154.76M | $12.40B | n/a | −1 |
| Q3 2024 | 21 | +1 | 104.49M | $9.40B | +1 | n/a |
| Q2 2024 | 20 | n/a | 97.49M | $7.67B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 60.04M | -0.7% | $5.44B | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 27.92M | +3.2% | $2.50B | 0.2% | ▲ Add | 4 | SEC ↗ ×2 |
| 3 | Norges Bank ✦ (passive) | 14.64M | +0.5% | $1.32B | 0.2% | ▲ Add | 4 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 10.06M | +42.9% | $903.91M | 0.1% | ▲ Add | 4 | SEC ↗ ×2 |
| 5 | Citadel Advisors ✦ | 8.66M | +45.1% | $778.29M | 0.8% | ▲ Add | 4 | SEC ↗ ×2 |
| 6 | Dodge & Cox ✦ | 7.71M | +0.6% | $692.72M | 0.4% | ▲ Add | 4 | SEC ↗ |
| 7 | Capital World Investors ✦ | 4.99M | New | $448.33M | 0.1% | New | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 3.97M | -68.0% | $356.50M | 0.1% | ▼ Trim | 4 | SEC ↗ ×8 |
| 9 | AQR Capital Management ✦ | 3.37M | +29.3% | $298.69M | 0.3% | ▲ Add | 4 | SEC ↗ ×7 |
| 10 | D. E. Shaw & Co. ✦ | 2.18M | +5.0% | $195.57M | 0.2% | ▲ Add | 4 | SEC ↗ ×2 |
| 11 | Adage Capital Partners ✦ | 1.73M | +4.2% | $155.11M | 0.3% | ▲ Add | 4 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 963.85K | +71.1% | $86.61M | 0.2% | ▲ Add | 4 | SEC ↗ |
| 13 | Millennium Management ✦ | 928.24K | -40.1% | $83.41M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 14 | Fisher Asset Management ✦ | 912.51K | -85.0% | $82.00M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | PRIMECAP Management ✦ | 667.11K | -8.3% | $59.95M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 16 | Baillie Gifford ✦ | 505.13K | -2.4% | $45.39M | 0.0% | ▼ Trim | 4 | SEC ↗ ×4 |
| 17 | Arrowstreet Capital ✦ | 345.98K | -70.8% | $31.09M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | Bridgewater Associates ✦ | 169.60K | -66.8% | $15.24M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 146.27K | -12.3% | $13.14M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 20 | Point72 Asset Management ✦ | 18.75K | -98.2% | $1.68M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | Marshall Wace ✦ | 4.55K | -98.9% | $408,863 | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Capital World Investors | $448.33M | 0.1% |
Exited
| Renaissance Technologies | $45.96M | was 0.1% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 2,204 holders, 1.04B shares, $87.65B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 10.42K sh · $1.00M
Officer, Director · 50.00K sh · $4.75M
Officer · 1.48K sh · $138,883
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology